Risk Assessment of Healthcare Workers at the Frontline against COVID-19
- PMID: 32582323
- PMCID: PMC7306961
- DOI: 10.12669/pjms.36.COVID19-S4.2790
Risk Assessment of Healthcare Workers at the Frontline against COVID-19
Abstract
The novel coronavirus disease 2019 (COVID-19) is a global pandemic. Healthcare workers (HCWs) are on the frontline of treating patients infected with COVID-19. However, data related to its infection rate among HCWs are limited. The aim was to present evidence associated with the number of HCWs being infected with COVID-19 from most viral affected countries (Italy, China, United States, Spain, and France). Furthermore, we looked into the reasons for HCWs COVID 19 infections and strategies to overcome this problem. Early available evidence suggested that HCWs are being increasingly infected with the novel infection ranging from 15% to 18% and in some cases up to 20% of the infected population. Major factors for infection among HCWs include lack of understanding of the disease, inadequate use and availability of Personal Protective Equipment (PPE), uncertain diagnostic criteria, unavailability of diagnostic tests and psychological stress. Therefore the protection of HCWs by authorities should be prioritized through education and training, the readiness of staff, incentives, availability of PPEs, and psychological support.
Keywords: COVID-19; Healthcare; Mortality Rate; Personal Protective Equipment; Risk.
Copyright: © Pakistan Journal of Medical Sciences.
Conflict of interest statement
Conflict of Interest: The authors declare no conflict of interests.
Figures
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China:Summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020 10.1001/jama.2020.2648. doi:10.1001/jama.2020.2648. - PubMed
-
- Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19) Asian Pac J Allergy Immunol. 2020;38(1):10–18. doi:10.12932/AP-200220-0773. - PubMed
-
- Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. Features, evaluation and treatment coronavirus (COVID-19) Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/ [Accessed 2nd April 2020] - PubMed
LinkOut - more resources
Full Text Sources